Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sarcoma 180 | 1 | 2009 | 6 | 0.390 |
Why?
|
Ultrasonics | 1 | 2009 | 211 | 0.340 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 1667 | 0.330 |
Why?
|
Acetonitriles | 1 | 2021 | 50 | 0.210 |
Why?
|
Apoptosis | 3 | 2021 | 10085 | 0.190 |
Why?
|
Carboxypeptidases | 1 | 2018 | 165 | 0.170 |
Why?
|
Lipid Peroxidation | 2 | 2009 | 311 | 0.170 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 4865 | 0.160 |
Why?
|
Myofibroblasts | 1 | 2018 | 220 | 0.150 |
Why?
|
Ultrasonography | 1 | 2009 | 5918 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 603 | 0.140 |
Why?
|
Adipose Tissue, White | 1 | 2018 | 354 | 0.140 |
Why?
|
Cell Line, Tumor | 3 | 2018 | 16959 | 0.140 |
Why?
|
DNA Helicases | 1 | 2020 | 825 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5197 | 0.130 |
Why?
|
Gene Deletion | 1 | 2020 | 2838 | 0.110 |
Why?
|
Lung Neoplasms | 3 | 2021 | 12183 | 0.110 |
Why?
|
Piperazines | 1 | 2021 | 2532 | 0.100 |
Why?
|
Diphenylhexatriene | 1 | 2009 | 13 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2022 | 13714 | 0.100 |
Why?
|
Membrane Fluidity | 1 | 2009 | 82 | 0.090 |
Why?
|
Annexins | 1 | 2009 | 44 | 0.090 |
Why?
|
Hydroxyl Radical | 1 | 2009 | 77 | 0.090 |
Why?
|
Cell Membrane | 2 | 2009 | 3892 | 0.090 |
Why?
|
Pyrimidines | 1 | 2021 | 2950 | 0.090 |
Why?
|
Pyridines | 1 | 2021 | 2862 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2936 | 0.090 |
Why?
|
Up-Regulation | 1 | 2018 | 4353 | 0.090 |
Why?
|
Cell Survival | 2 | 2009 | 6156 | 0.090 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2009 | 443 | 0.090 |
Why?
|
Ultrasonic Therapy | 1 | 2009 | 241 | 0.080 |
Why?
|
Alleles | 1 | 2018 | 7090 | 0.080 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2009 | 1001 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2018 | 3075 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2018 | 3234 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2018 | 5405 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5982 | 0.070 |
Why?
|
Multiple Myeloma | 1 | 2022 | 5044 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9556 | 0.070 |
Why?
|
Trans-Activators | 1 | 2015 | 3053 | 0.060 |
Why?
|
Mice, Nude | 2 | 2020 | 3859 | 0.060 |
Why?
|
Immunoglobulin Light Chains | 1 | 2022 | 258 | 0.050 |
Why?
|
Animals | 9 | 2022 | 170486 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2138 | 0.050 |
Why?
|
Sulfonamides | 2 | 2022 | 1938 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6571 | 0.050 |
Why?
|
Vero Cells | 1 | 2021 | 472 | 0.050 |
Why?
|
Transcription Factors | 1 | 2020 | 12005 | 0.050 |
Why?
|
Mice | 6 | 2022 | 80876 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2009 | 3021 | 0.050 |
Why?
|
Diphenylamine | 1 | 2018 | 52 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2009 | 6127 | 0.040 |
Why?
|
Amyloid | 1 | 2022 | 710 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 941 | 0.040 |
Why?
|
Virus Internalization | 1 | 2021 | 463 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11253 | 0.040 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2018 | 315 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22989 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 745 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 1400 | 0.040 |
Why?
|
Mitochondria | 1 | 2009 | 3665 | 0.030 |
Why?
|
Dexamethasone | 1 | 2022 | 1939 | 0.030 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2015 | 111 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 755 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 410 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2018 | 953 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 29262 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 20170 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14836 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1600 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2835 | 0.030 |
Why?
|
Benzamides | 1 | 2018 | 1406 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2020 | 2244 | 0.030 |
Why?
|
Stromal Cells | 1 | 2018 | 1361 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1906 | 0.030 |
Why?
|
Adipogenesis | 1 | 2015 | 349 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2040 | 0.030 |
Why?
|
Gene Silencing | 1 | 2018 | 1626 | 0.030 |
Why?
|
Fibrosis | 1 | 2018 | 1947 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 647 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3714 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3244 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 5112 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3507 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 1572 | 0.020 |
Why?
|
Humans | 7 | 2022 | 708843 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18712 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13298 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2015 | 2968 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 16008 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 15274 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9706 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10803 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2015 | 3866 | 0.010 |
Why?
|
Neoplasms | 1 | 2009 | 20172 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2018 | 11718 | 0.010 |
Why?
|
Infant | 1 | 2021 | 34261 | 0.010 |
Why?
|
Aged | 2 | 2021 | 161488 | 0.010 |
Why?
|
Female | 3 | 2021 | 375205 | 0.010 |
Why?
|
Diet | 1 | 2015 | 7392 | 0.010 |
Why?
|
Male | 3 | 2021 | 349524 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23950 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 12031 | 0.010 |
Why?
|
Middle Aged | 1 | 2021 | 213752 | 0.000 |
Why?
|
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_